Maxion Therapeutics Raises $72 million (£58 million) in an Oversubscribed Series A Financing to Advance its KnotBody® Pipeline and Platform
Maxion Therapeutics Raises $72 million (£58 million) in an Oversubscribed Series A Financing to Advance its KnotBody® ...
The Pharma Letter19h
Maxion Therapeutics raises $72 million
Cambridge, UK-based biotech start-up Maxion Therapeutics, which is developing antibody-based KnotBody drugs for ion channel- ...
Nature4d
G protein-coupled receptors articles from across Nature Portfolio
G protein-coupled receptors (GPCRs) are integral membrane proteins with seven membrane-spanning helices. Upon binding to a ligand – which can range from small molecules like cyclic AMP to ...
Business Weekly20h
International investors back Maxion Therapeutics in $72m Series A raise
Cambridge biotech Maxion Therapeutics has raised $72 million (£58m) in a Series A financing to further grow the business ...
The Pharma Letter13h
Partners aim to develop new class of obesity therapeutics
Abalone Bio, an antibody company measuring large-scale activity data to drive AI-powered discovery of active therapeutics, ...
Myrobalan Therapeutics Awarded a Grant from the National Multiple Sclerosis Society to Advance Development of MRO-002 in Multiple Sclerosis
Myrobalan to receive over $850,000 in funding to advance the development of its GPR17 antagonist for progressive MS from the ...
Salipro Biotech and Boehringer Ingelheim Enter Research and License Agreement to Accelerate Multiple Boehringer Ingelheim Pipeline Programs
Salipro Biotech AB, a Swedish biotech company specialising in the stabilisation of challenging drug targets, today announced a research and license agreement with ...
Contract Pharma4d
Boehringer Ingelheim Taps Salipro Biotech to Accelerate Pipeline Programs
Salipro Biotech has signed a research and license agreement with Boehringer Ingelheim to accelerate the development of ...
Knowridge Science Report5d
Study shows surprising link between gut health and high blood pressure
Researchers at Monash University have uncovered how the gut—and the food we eat—affects high blood pressure. Their discovery ...
Fierce Biotech4d
Sotio takes up option on ADCs, while Boehringer inks GPCR discovery pact
Sotio Biotech is pushing deeper into bispecific antibody-drug conjugates (ADC), taking up its option to use Synaffix’s ...
News Medical on MSN4d
How gut health shapes heart disease risk — and what you can do about it
A new review highlights how gut microbiome imbalances contribute to cardiovascular disease by altering short-chain fatty ...